Literature DB >> 21194985

Early and long-term outcome after thoracic endovascular aortic repair (TEVAR) for acute complicated type B aortic dissection.

J Steuer1, M-O Eriksson, R Nyman, M Björck, A Wanhainen.   

Abstract

OBJECTIVES: The study aimed to investigate early and long-term outcome of thoracic endovascular aortic repair (TEVAR) for acute complicated type B dissection.
DESIGN: This was a retrospective, single-centre, consecutive case series.
MATERIALS AND METHODS: During the period 1999-2009, TEVAR was carried out in 50 patients with non-traumatic acute complicated type B dissection, and in another 10 patients with acute complications, including rupture, end-organ ischaemia and acute dilatation during the primary hospitalisation, but >14 days after onset of symptoms. Thus, in total, 60 patients were included; 22 with a DeBakey type IIIa dissection and 38 with a type IIIb; median age was 67 years. Early (30-day) and long-term (5-year) survival, re-intervention rate and complications were recorded until 1 July 2010.
RESULTS: Within 30 days, two (3%) deaths, one (2%) paraplegia and three (5%) strokes were observed. Five-year survival was 87% and freedom from re-intervention at 5 years was 65%.
CONCLUSIONS: In patients with acute complicated type B aortic dissection, TEVAR can be performed with excellent early and long-term survival, whereas morbidity and long-term durability must be further elucidated.
Copyright © 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21194985     DOI: 10.1016/j.ejvs.2010.11.024

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  16 in total

1.  Endovascular therapy for thoracic aortic aneurysms: state of the art in 2012.

Authors:  Nicolas A Brozzi; Eric E Roselli
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-04

2.  Management of aortic dissection: medical therapy and intervention. Is there a growing role for endovascular techniques?

Authors:  Kristine C Orion; James H Black
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-06

Review 3.  Treatment of uncomplicated type B aortic dissection.

Authors:  Hitoshi Matsuda
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-12-05

4.  Percutaneous thoracic endovascular aortic repair is not contraindicated in obese patients.

Authors:  Jason Zakko; Salvatore Scali; Adam W Beck; Charles T Klodell; Thomas M Beaver; Tomas D Martin; Thomas S Huber; Robert J Feezor
Journal:  J Vasc Surg       Date:  2014-05-17       Impact factor: 4.268

5.  Best surgical option for arch extension of type B dissection: the endovascular approach.

Authors:  Toru Kuratani
Journal:  Ann Cardiothorac Surg       Date:  2014-05

Review 6.  Management of complicated and uncomplicated acute type B dissection. A systematic review and meta-analysis.

Authors:  Konstantinos G Moulakakis; Spyridon N Mylonas; Ilias Dalainas; John Kakisis; Thomas Kotsis; Christos D Liapis
Journal:  Ann Cardiothorac Surg       Date:  2014-05

Review 7.  Lower limb malperfusion in type B aortic dissection: a systematic review.

Authors:  Mauro Gargiulo; Claudio Bianchini Massoni; Enrico Gallitto; Antonio Freyrie; Santi Trimarchi; Gianluca Faggioli; Andrea Stella
Journal:  Ann Cardiothorac Surg       Date:  2014-07

8.  Endovascular repair of acute complicated type B aortic dissection-systematic review and meta-analysis of long-term survival and reintervention.

Authors:  Ashley R Wilson-Smith; Benjamin Muston; Harish Kamalanathan; Amanda Yung; Cheng-Hao Jacky Chen; Prachi Sahai; Aditya Eranki
Journal:  Ann Cardiothorac Surg       Date:  2021-11

9.  [Traumatic aortic rupture and concomitant type B aortic dissection after skiing accident].

Authors:  D Jost; T Schachner; C Czuprin; G Richter; T Hupp
Journal:  Unfallchirurg       Date:  2014-01       Impact factor: 1.000

10.  Management of acute type B aortic dissection with malperfusion via endovascular fenestration/stenting.

Authors:  Elizabeth L Norton; David M Williams; Karen M Kim; Minhaj S Khaja; Xiaoting Wu; Himanshu J Patel; G Michael Deeb; Bo Yang
Journal:  J Thorac Cardiovasc Surg       Date:  2019-09-30       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.